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plthough the expectations of clinicians caring for patients
ith coronary artery disease from imagers are enormous,
hey are fairly straightforward. Clinicians need assistance in
he identification of patients who are at very high risk of
eveloping acute coronary events. In a large proportion of
reviously asymptomatic individuals, sudden coronary death
r acute myocardial infarction occurs as the first manifesta-
ion of coronary atherosclerosis. Therefore, treating such
vents is analogous to locking the barn door after the horse
as been stolen. Although such acute events were accepted
s natural but unavoidable manifestations of coronary ath-
rosclerosis in the past, it is now increasingly clear that
atients experiencing these events may have subclinical
isease and usually exhibit classical or novel risk factors.
learly, the prevention of such events is now a very
mportant goal.
Hypercholesterolemia, hypertension, cigarette smoking,
nd diabetes mellitus were identified as risk factors for
oronary disease about 50 years ago. The modern integra-
ion of these risk factors together with age and gender into
he Framingham risk score allows classification of patients
nto low-, intermediate-, and high-risk categories for the
ikelihood of development of acute coronary events (1)
Fig. 1).
Individuals with a risk of developing an acute coronary
vent over the next decade of up to approximately 5%, or
0.5% per year, are arbitrarily considered to be at “low” risk.
hose who carry a risk of 5% to 20% over a 10-year period
0.5% to 2% per year) are at “intermediate” risk. And those
ith an acute coronary event rate of more than 20% over a
ecade (2% per year) are generally considered to be at
high” risk (2).
Almost half of the adult population in the U.S. and
estern Europe belongs to the low-risk group. A common
xample of a low-risk person would be a 40-year-old woman
ithout any detectable risk factors. Such individuals should
eceive lifestyle advice and serial follow-up. Because of the
reat prevalence of this low-risk population, the total
umber of actual coronary events in them is high and a
ariety of genomic and proteomic approaches to further risk
tratify this group are now under intense investigation.
Approximately 40% of the population is at intermediate
isk. A typical individual in this category would be a
5-year-old man with hypertension who is a nonsmoker and
oes not have hypercholesterolemia, diabetes, or a family
istory of coronary disease. In such individuals, additional
From the TIMI Study Group, Cardiovascular Division, Brigham and Women’s
ospital, and Department of Medicine, Harvard Medical School, Boston,h
assachusetts.
Manuscript received June 17, 2005, accepted October 11, 2005.esting may be helpful to aid in further risk stratification
Fig. 2). For example, determining the high-sensitivity
-reactive protein (hsCRP) level is a simple inexpensive test
hat is helpful in this regard (3). The ankle-brachial index
lso is a relatively inexpensive test and is not time or labor
ntensive and can add further information (4). Such addi-
ional testing may allow reclassification of intermediate-risk
atients into either low- or high-risk categories. For in-
tance, if the hypertensive man described above exhibits a
ow hsCRP concentration, 1 mg/l, he may be reclassified
s low risk and be a candidate for control of hypertension
nd follow-up, whereas if his hsCRP is elevated, 3 mg/l,
his would place him into a higher risk category. Ultrasono-
raphic measurement of the carotid artery intimal-medial
all thickness (5), the “coronary calcium score” derived from
lectron-beam computerized tomography (6), or magnetic
esonance imaging of the thoracic aorta and the walls of the
arotid arteries and the proximal coronary arteries (7,8) also
ay be useful. However, the accuracy and cost-effectiveness
f these more expensive imaging tests in large populations
as yet to be determined.
The high-risk category includes the remaining one-sixth
f the adult population. Such individuals are known to have
oronary, cerebral, or peripheral vascular disease or to suffer
rom diabetes mellitus or renal dysfunction. This category
ay also include patients upgraded from intermediate risk
y additional testing. Patients identified as being at high
isk should receive intense global risk factor reduction. In
ddition, these patients need further stratification to identify
hose with vulnerable plaques who are at very high risk
15% acute coronary events per year). Identification of
hese “accidents waiting to happen” is a key goal for
oronary artery imaging.
A number of new potent agents to suppress the inflam-
ation that leads to rupture of vulnerable coronary plaques
re now on the horizon, but it is unlikely that their systemic
dministration will be free of risk and therefore they will
ave to be used selectively. Other radical strategies to
rotect “vulnerable patients” could involve the implantation
f multiple drug-eluting stents, or even coronary surgery to
ypass multiple unstable plaques in the proximal coronary
rterial tree. Obviously, careful risk-benefit analyses will
eed to be carried out with these therapeutic approaches. In
he near term, imaging to identify multiple high-risk vul-
erable plaques will require an invasive approach to be
ncorporated into the coronary arteriographic examination.
iven the multicentricity of vulnerable plaques (9), the
roximal segments of all three major coronary arteries will
ave to be examined. This accomplishment appears to be
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ent. The ultimate goal, however, will be to identify such
laques by noninvasive imaging. Such an achievement,
hich still seems far off, could be the real solution to this
igure 1. Risk stratification in coronary disease. The standard risk stratifica
s traditionally considered to be 2% per year. However, since such patien
e placed into a separate category. Identification of a very-high-risk categ
nstable coronary plaques.
igure 2. Proposed algorithm for the detection of plaques likely to re
ntermediate-, and high-risk categories, using the Framingham risk score (
t very high risk will need development of tests that characterize vessel wall and
nter  intermediate; F/U  follow-up; V.  very; New Rx  new treatmentritical medical problem. Thus, clinicians’ expectations of
he imagers are very high indeed; close collaboration of
hese two groups to reach this important goal is of the
tmost importance.
llocates subjects to low-, intermediate-, and high-risk categories. High risk
y also include those at very high annual risk (15%), the latter deserve to
ill require development of imaging techniques aimed at the detection of
n acute coronary syndromes. After the initial stratification into low-,
and defined by the estimated event rate per year, identification of patientstion a
ts masult i
FRS)identification of vulnerable plaques (VP), not simply luminal obstruction.
modes.
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